Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron N Winn

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Journal of the National Cancer Institute|October 23, 2018
Making Sure We Don't Forget the Basics When Using Machine LearningAaron N Winn, Joan M Neuner
BMJ (Clinical Research Ed.)|December 4, 2023
Authors' reply to LaurentAaron P Mitchell, Aaron N Winn
Pharmacoepidemiology and Drug Safety|April 30, 2016
The association between trajectories of endocrine therapy adherence and mortality among women with breast cancerAaron N Winn, Stacie B Dusetzina
American Journal of Obstetrics and Gynecology|May 25, 2019
Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysisKemi M Doll, Aaron N Winn
Cancer|December 20, 2018
More evidence on the limited impact of state oral oncology parity lawsAaron N Winn, Stacie B Dusetzina
Current Diabetes Reports|April 26, 2017
The Role of the FDA and Regulatory Approval of New Devices for Diabetes CareShelley A Jazowski, Aaron N Winn
Journal of the American Pharmacists Association : Japha|May 8, 2021
Clinician burnout during the COVID-19 pandemic before vaccine administrationBrianne K Bakken, Aaron N Winn
Annals of Internal Medicine|February 21, 2023
Web Exclusive. Annals On Call - First-Line Drug Therapy for Type 2 DiabetesRobert M Centor, Neda Laiteerapong, Aaron N Winn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid LeukemiaAaron N Winn, Nancy L Keating, Stacie B Dusetzina
Medical Care|November 30, 2018
Using Group-based Trajectory Models and Propensity Score Weighting to Detect Heterogeneous Treatment Effects: The Case Study of Generic Hormonal Therapy for Women With Breast CancerAaron N Winn, Nicole M Fergestrom, Joan M Neuner
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|October 23, 2018
Making Sure We Don't Forget the Basics When Using Machine LearningAaron N Winn, Joan M Neuner
BMJ (Clinical Research Ed.)|December 4, 2023
Authors' reply to LaurentAaron P Mitchell, Aaron N Winn
Pharmacoepidemiology and Drug Safety|April 30, 2016
The association between trajectories of endocrine therapy adherence and mortality among women with breast cancerAaron N Winn, Stacie B Dusetzina
American Journal of Obstetrics and Gynecology|May 25, 2019
Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysisKemi M Doll, Aaron N Winn
Cancer|December 20, 2018
More evidence on the limited impact of state oral oncology parity lawsAaron N Winn, Stacie B Dusetzina
Current Diabetes Reports|April 26, 2017
The Role of the FDA and Regulatory Approval of New Devices for Diabetes CareShelley A Jazowski, Aaron N Winn
Journal of the American Pharmacists Association : Japha|May 8, 2021
Clinician burnout during the COVID-19 pandemic before vaccine administrationBrianne K Bakken, Aaron N Winn
Annals of Internal Medicine|February 21, 2023
Web Exclusive. Annals On Call - First-Line Drug Therapy for Type 2 DiabetesRobert M Centor, Neda Laiteerapong, Aaron N Winn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid LeukemiaAaron N Winn, Nancy L Keating, Stacie B Dusetzina
Medical Care|November 30, 2018
Using Group-based Trajectory Models and Propensity Score Weighting to Detect Heterogeneous Treatment Effects: The Case Study of Generic Hormonal Therapy for Women With Breast CancerAaron N Winn, Nicole M Fergestrom, Joan M Neuner
Pageof 8